Cabozantinib plus atezolizumab improved progression-free survival in advanced prostate cancer after ARPI failure.

Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

Breast, head and neck, lung and cervical cancer account for 60 per cent of India’s radiotherapy needs, says the study.

After Teddi Mellencamp shared her cancer had progressed earlier this year, she shared why she has felt “sicker” amid ...

King Charles recently offered a rare personal update on his health during a royal visit, showing signs of recovery more than a year after his cancer diagnosis.

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of ...

Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

Hours after Teddi Mellencamp and her estranged husband Edwin Arroyave’s Los Angeles home was burglarized on July 21, The Real ...

Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...

City of Hope Research Spotlight offers a glimpse into groundbreaking scientific and clinical discoveries advancing lifesaving ...

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...